Alla Gimelfarb to Imatinib Mesylate
This is a "connection" page, showing publications Alla Gimelfarb has written about Imatinib Mesylate.
Connection Strength
0.029
-
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib. Blood. 2014 Jun 05; 123(23):3574-7.
Score: 0.029
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.